BACKGROUND: Measurement of plasma fibrinogen is often required in critically ill patients or massively bleeding patients being resuscitated with colloid plasma expander. This study aimed at evaluating different assays of plasma fibrinogen after in vitro dilution with commonly used plasma expanders and challenged the hypothesis that levels of fibrinogen are estimated significantly higher in plasma diluted with colloid plasma expander compared with isotonic saline.STUDY DESIGN AND METHODS: Fibrinogen measurements were established in plasma samples each diluted in vitro to 30 or 50% with isotonic saline, hydroxyethyl starch (HES) 130/0.4, and human albumin. Fibrinogen levels were assessed using an antigen determination, three photo-optical Cla...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
Background: Adequate fibrinogen concentration is a crucial component of sufficient perioperative/pos...
Background: The efficacy of concentrates of fibrinogen and factor XIII in hypothermia and haemodilut...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Replacement of fibrinogen is presumably the key step in managing dilutional coagulopathy. We perform...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Background: Fibrinogen, a plasma protein essential for clot formation, can reach critically low leve...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
BACKGROUND: Bleeding upon major surgery or severe trauma is treated by transfusion with crystalloids...
BACKGROUND:In this in vitro trial, we assessed the effect on blood coagulation of 60% dilution with ...
Both congenital and acquired fibrinogen deficiency can be safely treated with administration of fibr...
Both congenital and acquired fibrinogen deficiency can be safely treated with administration of fibr...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
Background: Adequate fibrinogen concentration is a crucial component of sufficient perioperative/pos...
Background: The efficacy of concentrates of fibrinogen and factor XIII in hypothermia and haemodilut...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Replacement of fibrinogen is presumably the key step in managing dilutional coagulopathy. We perform...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Background: Fibrinogen, a plasma protein essential for clot formation, can reach critically low leve...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
Background and Aims: Human plasma protein fraction 5% (PPF5%) is an albumin-based colloid used to ex...
BACKGROUND: Bleeding upon major surgery or severe trauma is treated by transfusion with crystalloids...
BACKGROUND:In this in vitro trial, we assessed the effect on blood coagulation of 60% dilution with ...
Both congenital and acquired fibrinogen deficiency can be safely treated with administration of fibr...
Both congenital and acquired fibrinogen deficiency can be safely treated with administration of fibr...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...
INTRODUCTION: Hemolysate in plasma samples from patients may cause misleading results in coagulation...